An intensified manufacturing process developed to support a trial of an Ebola vaccine in Uganda could help accelerate the production of other jabs in future health emergencies, according to Italian ...

If we want our vaccine production process to be more robust and faster, we’ll have to stop relying on chicken eggs. This article first appeared in The Checkup, MIT Technology Review’s weekly biotech ...

Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...

Every year, a significant number of individuals across the globe contract the influenza virus, leading to the manifestation of severe symptoms and, in some cases, fatal outcomes, thereby posing a ...